Lerozot 2.5 Tablet helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body.

Lerozot 2.5 Tablet is used to treat breast cancer in women who have gone through the menopause.

Uses of Lerozot Tablet

Treatment of Breast cancer
Treatment of Infertility due to anovulation

Benefits of Lerozot Tablet

In Treatment of Breast cancer

Lerozot 2.5 Tablet relieves the symptoms of breast cancer such as breast lumps, bloody discharge from the nipple, or changes in the shape or texture of the breast. It works by altering the production of those hormones in the body that are essential for the growth and spread of breast cancer. It may also interact with other hormones or have a direct effect on cancer to stop its growth.

In Treatment of Infertility due to anovulation

Lerozot 2.5 Tablet helps in the normal development of an egg in a woman's ovary (female reproductive organ) and stimulates the release of the egg during a process called ovulation. This helps to treat infertility in women. This increases the chance of a successful pregnancy. You should use the medicine as prescribed for it to be effective.

show less

Side effects of Lerozot Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Lerozot

Fatigue
Hypercholesterolemia (high cholesterol)
Increased sweating
Hot flashes
Bone pain
Dizziness
Joint pain
Edema (swelling)
Flushing (sense of warmth in the face, ears, neck and trunk)

How to use Lerozot Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lerozot 2.5 Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

SAFE

Consuming alcohol with Lerozot 2.5 Tablet does not cause any harmful side effects.

Pregnancy

UNSAFE

Lerozot 2.5 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Breast feeding

UNSAFE

Lerozot 2.5 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

UNSAFE

Lerozot 2.5 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

SAFE IF PRESCRIBED

Lerozot 2.5 Tablet is safe to use in patients with kidney disease. No dose adjustment of Lerozot 2.5 Tablet is recommended.
However, there is limited information on the use of this medicine in patients with end stage kidney disease. Please consult with your doctor.

Liver

CAUTION

Lerozot 2.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Lerozot 2.5 Tablet may be needed. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Lerozot 2.5 Tablet

₹44.68/Tablet

Letroz Tablet

Sun Pharmaceutical Industries Ltd

₹13.14/tablet

71% cheaper

Stimufol 2.5mg Tablet

Intas Pharmaceuticals Ltd

₹29.29/tablet

34% cheaper

Fempro Tablet

Cipla Ltd

₹8.95/tablet

80% cheaper

Mamazol 2.5mg Tablet

Khandelwal Laboratories Pvt Ltd

₹16.17/tablet

64% cheaper

Letero Tablet

Hetero Drugs Ltd

₹7.9/tablet

82% cheaper

View all substitutes

Quick tips

You have been prescribed Lerozot 2.5 Tablet for the treatment of breast cancer or infertility due to anovulation.
It can be taken with or without food.
Do not drive or do anything requiring concentration until you know how Lerozot 2.5 Tablet affects you.
It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes.
Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as Lerozot 2.5 Tablet can alter their levels.
Do not take Lerozot 2.5 Tablet if you are pregnant or breastfeeding

Fact Box

Chemical Class

Diphenylmethane Derivative

Habit Forming

Therapeutic Class

abcde

Action Class

Aromatase inhibitor

FAQs

Why have I been prescribed Lerozot 2.5 Tablet?

Lerozot 2.5 Tablet is an aromatase inhibitor. It is generally prescribed to treat breast cancer in women who no longer have periods, either due to menopause or after surgery or chemotherapy. It is also used to treat infertility caused due to anovulation (during menstrual cycle egg cell from ovaries is not released).

How does Lerozot 2.5 Tablet work?

Lerozot 2.5 Tablet is also known as an anti-estrogen drug. It is called so because it acts by reducing the production of estrogen in your body by blocking the enzyme aromatase, which is responsible for the production of estrogen. Estrogen stimulates the production of certain types of breast cancer in your body. These cancers are called "estrogen-dependent cancers". Reducing the production of estrogen may prevent cancer from growing.

For how long should I take Lerozot 2.5 Tablet?

If the breast tumor is in the advanced stage or has spread to other parts of the body, it is recommended that you continue taking Lerozot 2.5 Tablet till the tumor shows progression. In cases where Lerozot 2.5 Tablet is given after tamoxifen (another anti-estrogen used for breast cancer) or surgery, it should be given for 5 years or until the tumor comes back, whichever is first. It can also be given as a sequential treatment; 2 years of Lerozot 2.5 Tablet followed by 3 years of tamoxifen.

If I am taking irbesartan to control my blood pressure, can I take Lerozot 2.5 Tablet?

Yes, you can take irbesartan and Lerozot 2.5 Tablet together. However, be careful and keep a regular check on your blood pressure since Lerozot 2.5 Tablet may increase your blood pressure. Consult your doctor in case you have problems controlling your blood pressure.

Does Lerozot 2.5 Tablet affect vision?

Although it is very uncommon, Lerozot 2.5 Tablet may cause a cataract. So, if you experience blurred vision or eye irritation, consult your doctor immediately.

My friend who is taking Lerozot 2.5 Tablet often sweats a lot. Is it because of Lerozot 2.5 Tablet?

This could be a sign of hot flushes which is a very common side effect of Lerozot 2.5 Tablet. It happens due to decreased estrogen levels. The frequency of hot flushes reduces once your body adjusts to Lerozot 2.5 Tablet. However, in some people, the flushes and sweats may continue during the treatment and stop a few months after the treatment finishes. You can consult your doctor who will provide you a remedy if it is very bothersome.

What are the serious side effects of Lerozot 2.5 Tablet?

The serious side effects do not occur in everyone and very few people experience them. The serious side effects of Lerozot 2.5 Tablet include stroke, angina, heart attack, blood clotting, cataract, osteoporosis, and severe skin reactions.

Show less

Related lab tests

Breast Cancer (CA 15.3/ ER/ PR)

Related ayurvedic ingredients

Olive oil

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Moy B, Lee RJ, Smith M. Natural Products in Cancer Chemotherapy: Hormones and Related Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1762.
Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 718.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 786-87.
Letrozole. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 1997 [revised Jan. 2014]. [Accessed 03 Apr. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
National Health Service. Letrozole. [Last Reviewed: 21 Jul 2020]. [Accessed 08 Jul. 2023]. (online) Available from:
Letrozole [Package Insert]. Mumbai, India: HOPE Lifecare. [Accessed 08 Jul. 2023]. (online) Available from:
Letrozole [Prescribing Information]. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2020. [Accessed 08 Jul. 2023]. (online) Available from:

Marketer details

Name: Care Formulation Labs Pvt Ltd

Address: D-1659, DSIIDC, Narela Industrial Area, Delhi, 110040

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.